Vaxcyte, Inc. Balance Sheet
PCVX / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Vaxcyte, Inc. had $3.0B in total assets and $2.7B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $174.0M | $387.9M | $397.5M | $834.7M | $69.0M | $386.2M | $59.0M | - |
| Current Assets | $1.6B | $1.8B | $1.1B | $942.6M | $256.3M | $389.0M | $61.7M | - |
| PP&E (Net) | $257.4M | $198.0M | $79.6M | $10.4M | $8.0M | $3.3M | $3.4M | - |
| Total Assets | $3.0B | $3.5B | $1.4B | $1.0B | $324.3M | $392.8M | $65.7M | - |
| Current Liabilities | $205.8M | $140.2M | $145.3M | $40.5M | $28.7M | $46.9M | $11.1M | - |
| Shareholders' Equity | $2.7B | $3.3B | $1.2B | $953.6M | $284.0M | $345.8M | -$106.4M | -$57.7M |